As of September 29, 2026, the three largest insider holders of RNXT are Ramtin Agah (Chief Medical Officer, 975.00K shares), Ramtin Agah (Chief Medical Officer, 798.46K shares), Shaun Bagai (Chief Executive Officer, 340.04K shares).
| # | Insider | Position | Direct | Indirect | Total | Share of Insiders | Last Filed |
|---|---|---|---|---|---|---|---|
| 1 | Ramtin Agah | Chief Medical Officer | 798,460 | 0 | 798,460 | 55.5% | 22 Jan, 2026 |
| 2 | Shaun Bagai | Chief Executive Officer | 0 | 313,357 | 313,357 | 21.8% | 24 Mar, 2026 |
| 3 | Mark Voll | Chief Financial Officer | 222,380 | 0 | 222,380 | 15.4% | 15 Sep, 2026 |
| 4 | Robert J. Spiegel | Director | 40,983 | 0 | 40,983 | 2.8% | 30 Jan, 2024 |
| 5 | K. Angela Macfarlane | Director | 40,983 | 0 | 40,983 | 2.8% | 30 Jan, 2024 |
| 6 | Ron Kocak | Vp Controller And Pao | 12,595 | 0 | 12,595 | 0.9% | 10 Apr, 2025 |
| 7 | Laurence Marton | Director | 0 | 9,720 | 9,720 | 0.7% | 24 Mar, 2026 |
| 8 | Angela Nelms | Chief Operating Officer | 1,100 | 0 | 1,100 | 0.1% | 04 Oct, 2023 |
Each row is that insider’s most recently reported position, from Form 4 filings over the last 60 months — which is why this total does not tie to the quarterly series above, where a quarter counts only the insiders who filed in it. Shares held through a fund or institutional portfolio are counted on the institutional ownership page instead.
| Date | Insider | Position | Transaction | Shares | Price | Value | Shares Held After | Ownership |
|---|---|---|---|---|---|---|---|---|
| 19 May, 2026 | Mark Voll | Chief Financial Officer | Acquired P | 25,000 | $0.79 | $19.69K | 142,380 | Direct |
| 03 Apr, 2026 | Mark Voll | Chief Financial Officer | Acquired A | 80,000 | $0.00 | $0 | 117,380 | Direct |
| 03 Apr, 2026 | Shaun Bagai | Chief Executive Officer | Acquired A | 946,107 | $0.00 | $0 | 946,107 | Direct |
| 03 Apr, 2026 | Leesa Gentry | Chief Clinical Officer | Acquired A | 128,550 | $0.00 | $0 | 128,550 | Direct |
| 03 Apr, 2026 | Ramtin Agah | Chief Medical Officer | Acquired A | 621,727 | $0.00 | $0 | 621,727 | Direct |
| 25 Mar, 2026 | Mark Voll | Chief Financial Officer | Acquired A | 12,380 | $0.00 | $0 | 37,380 | Direct |
| 20 Mar, 2026 | Shaun Bagai | Chief Executive Officer | Acquired P | 24,300 | — | — | 313,357 | Indirect |
| 20 Mar, 2026 | Mark Voll | Chief Financial Officer | Acquired P | 97,200 | — | — | 97,200 | Indirect |
| 20 Mar, 2026 | Laurence Marton | Director | Acquired P | 9,720 | — | — | 9,720 | Indirect |
| 20 Mar, 2026 | Mark Voll | Chief Financial Officer | Acquired P | 48,600 | — | — | 48,600 | Indirect |
| 20 Mar, 2026 | Laurence Marton | Director | Acquired P | 4,860 | — | — | 4,860 | Indirect |
| 20 Mar, 2026 | Shaun Bagai | Chief Executive Officer | Acquired P | 12,150 | — | — | 12,150 | Indirect |
| 21 Jan, 2026 | Ramtin Agah | Chief Medical Officer | Acquired P | 10,000 | $1.00 | $9.98K | 798,460 | Direct |
| 31 Dec, 2025 | Ramtin Agah | Chief Medical Officer | Acquired P | 9,795 | $0.86 | $8.42K | 788,460 | Direct |
| 30 Dec, 2025 | Ramtin Agah | Chief Medical Officer | Acquired P | 205 | $0.83 | $169 | 778,665 | Direct |
| 18 Dec, 2025 | Shaun Bagai | Chief Executive Officer | Acquired P | 5,000 | $0.90 | $4.51K | 340,040 | Direct |
| 17 Dec, 2025 | Shaun Bagai | Chief Executive Officer | Acquired P | 5,000 | $0.85 | $4.26K | 335,040 | Direct |
| 16 Dec, 2025 | Ramtin Agah | Chief Medical Officer | Acquired P | 12,000 | $0.85 | $10.20K | 778,460 | Direct |
| 05 Dec, 2025 | Ramtin Agah | Chief Medical Officer | Acquired P | 10,000 | $0.96 | $9.60K | 766,460 | Direct |
| 21 Nov, 2025 | Ramtin Agah | Chief Medical Officer | Acquired P | 10,000 | $0.80 | $8.00K | 744,460 | Direct |